A hypnotic drug is any medication designed to induce or maintain sleep. The term covers a broad range of prescription sleep aids, from older barbiturates to modern medications that target the brain’s wakefulness signals. Most hypnotics work by amplifying the activity of GABA, the brain’s primary calming chemical, though newer options take a completely different approach. These drugs are classified as controlled substances due to their potential for dependence.
How Hypnotics Work in the Brain
The majority of hypnotic drugs share one basic mechanism: they boost the effect of GABA, a neurotransmitter that slows brain activity. When GABA binds to its receptors on nerve cells, it makes those cells less likely to fire. Hypnotics amplify this process, tipping the brain toward sedation and sleep.
Not all hypnotics interact with GABA receptors in the same way. Older drugs like barbiturates and benzodiazepines bind broadly across multiple types of GABA receptors, which is why they affect not just sleep but also anxiety, muscle tension, and seizure activity. Newer sleep-specific medications, often called Z-drugs, are more selective. They preferentially target a specific subtype of GABA receptor (the alpha-1 subtype) that mediates sedation without as much influence on other brain functions. Research in the British Journal of Pharmacology confirmed that the sedative effect of zolpidem, the most widely prescribed Z-drug, is entirely mediated through this single receptor subtype.
A newer class of hypnotics works through a completely different pathway. Dual orexin receptor antagonists (DORAs) don’t enhance sedation at all. Instead, they block orexin, a chemical that promotes wakefulness. The distinction matters: rather than pushing the brain into a sedated state, these drugs remove the signals keeping you awake, which tends to preserve normal sleep architecture more naturally.
Major Classes of Hypnotic Drugs
Benzodiazepines
Benzodiazepines have been prescribed for decades to treat insomnia, anxiety, epilepsy, and other conditions. They bind broadly to GABA receptors, producing sedation alongside muscle relaxation and anxiety relief. This broad activity is a double-edged sword: it makes them versatile but also increases the risk of grogginess, impaired coordination, and dependence. Some benzodiazepines stay active in the body for many hours, which can cause significant next-day drowsiness, particularly in older adults.
Z-Drugs
Z-drugs (zolpidem, zaleplon, eszopiclone, and zopiclone) were introduced in the 1990s as a more targeted alternative to benzodiazepines. Despite having a different chemical structure, they act on the same GABA receptor system but with greater selectivity for the sedation-specific subtype. They are approved only for insomnia, unlike benzodiazepines which serve multiple purposes. Eszopiclone, for example, is typically started at 1 mg before bedtime and can be increased to a maximum of 3 mg (or 2 mg for older adults). All Z-drugs are Schedule IV controlled substances, the same classification as benzodiazepines.
Orexin Receptor Antagonists
The first DORA, suvorexant, was approved in the United States in 2014. Lemborexant followed in 2019, and daridorexant received approval more recently in both North America and the European Union. These drugs stand apart because they preserve the natural balance between REM and non-REM sleep phases. Benzodiazepines and Z-drugs can distort this balance, sometimes reducing the deeper sleep stages your body needs most. Daridorexant, the newest option, blocks both types of orexin receptors equally, suppressing both arousal and wake-promoting signals.
Other Hypnotic Options
Several other drug classes are sometimes used for their sedating properties, including certain antihistamines, melatonin-based medications, some antidepressants, and anticonvulsants. These aren’t always classified as hypnotics in the traditional sense, but they’re frequently prescribed off-label for sleep problems. Barbiturates, once the dominant sleep medication, are rarely used for insomnia today due to their high risk of overdose and dependence.
Side Effects and Risks
The most well-known side effect of hypnotic drugs is next-morning grogginess, sometimes called a “hangover” effect. A 2014 meta-analysis found that driving performance worsened significantly with longer-acting agents, higher doses, and shorter gaps between taking the medication and getting behind the wheel. This is one reason dosing guidelines are conservative, especially for older adults.
Complex sleep behaviors are a more alarming risk. Zolpidem in particular has been linked to sleepwalking, sleep-related eating (where people prepare and consume food with no memory of doing so), and other behaviors performed while not fully awake. Case reports of these events have also appeared with zaleplon and suvorexant, though less frequently. Nightmares and REM sleep behavior disorder, where people physically act out dreams, are among the most commonly reported drug-induced sleep disturbances across hypnotic classes.
Falls are a serious concern for older adults taking any GABA-based hypnotic. The sedation, combined with effects on balance and coordination, increases fall risk. This isn’t due to any direct effect on bone health but rather the impairment of gait and cognition, particularly in people who already have mobility issues. The risk tends to be highest during the early treatment period and at higher doses.
Dependence and Withdrawal
Hypnotic drugs, particularly benzodiazepines and Z-drugs, carry a real risk of physical dependence. With regular use, the brain adapts to the presence of the drug, and stopping abruptly can trigger a withdrawal syndrome. Symptoms of withdrawal include anxiety, tremors, nightmares, insomnia (often worse than the original sleep problem), poor appetite, rapid pulse, rapid breathing, blood pressure swings, dangerously high fever, and in severe cases, seizures.
The pattern of dependence often follows a recognizable trajectory: a growing tolerance to the drug’s effects, unsuccessful attempts to cut back, and continued use despite recognizing problems the drug is causing. Harvard Health describes this as sedative-hypnotic use disorder, a formal diagnosis that captures the full spectrum from mild dependence to severe addiction. For this reason, most prescribing guidelines recommend using hypnotics at the lowest effective dose for the shortest practical duration.
Newer orexin receptor antagonists appear to carry a lower risk of dependence based on their different mechanism, though long-term data is still limited compared to the decades of experience with GABA-based drugs. Their ability to promote sleep without broadly suppressing brain activity is one reason they’ve generated interest as a potentially safer long-term option for chronic insomnia.